Early-time-point 18F-FDG-PET/CT and other prognostic biomarkers of survival in metastatic melanoma patients receiving immunotherapy
Authors
Nezka Hribernik
Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia
Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
Katja Strasek
Faculty of Mathematics and Physics, University of Ljubljana, Ljubljana, Slovenia
Andrej Studen
Faculty of Mathematics and Physics, University of Ljubljana, Ljubljana, Slovenia
Experimental Particle Physics Department, Jozef Stefan Institute, Ljubljana, Slovenia
Katarina Zevnik
Department of Nuclear Medicine, Institute of Oncology Ljubljana, Ljubljana, Slovenia
Katja Skalic
Department of Nuclear Medicine, Institute of Oncology Ljubljana, Ljubljana, Slovenia
Robert Jeraj
Faculty of Mathematics and Physics, University of Ljubljana, Ljubljana, Slovenia
University of Wisconsin Carbone Cancer Centre, Madison, USA
Department of Medical Physics, University of Wisconsin-Madison, Madison, USA
Experimental Particle Physics Department, Jozef Stefan Institute, Ljubljana, Slovenia
Martina Rebersek
Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia
Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
Language: English
Page range: 43 - 53
Submitted on: Dec 12, 2024
Accepted on: Jan 4, 2025
Published on: Feb 27, 2025
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2025 Nezka Hribernik, Katja Strasek, Andrej Studen, Katarina Zevnik, Katja Skalic, Robert Jeraj, Martina Rebersek, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.